Cargando…
Identifying Patients With Rapid Progression From Hormone-Sensitive to Castration-Resistant Prostate Cancer: A Retrospective Study
Prostate cancer (PCa) is the second most prevalent malignancy and the fifth cause of cancer-related deaths in men. A crucial challenge is identifying the population at risk of rapid progression from hormone-sensitive prostate cancer (HSPC) to lethal castration-resistant prostate cancer (CRPC). We co...
Autores principales: | Pan, Chenxi, He, Yi, Wang, He, Yu, Yang, Li, Lu, Huang, Lingling, Lyu, Mengge, Ge, Weigang, Yang, Bo, Sun, Yaoting, Guo, Tiannan, Liu, Zhiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491655/ https://www.ncbi.nlm.nih.gov/pubmed/37394064 http://dx.doi.org/10.1016/j.mcpro.2023.100613 |
Ejemplares similares
-
A Novel Nomogram for Identifying the Patients at Risk for Rapid Progression of Advanced Hormone-Sensitive Prostate Cancer
por: Wu, Mingshuang, et al.
Publicado: (2023) -
DIA-Based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2021) -
Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
por: Grenader, Tal, et al.
Publicado: (2010) -
Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer
por: Liu, Yufei, et al.
Publicado: (2020) -
Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer
por: Tamada, Satoshi, et al.
Publicado: (2018)